Clinical studies suggest that suPAR has an additive value to high-sensitivity C-reactive protein (hsCRP) or interleukin-6 (IL-6) in characterizing systemic inflammation in cardiovascular diseases [11]. Here, IL6 is linked to cardiovascular disorder.